Skip to main content

Animations

MJFF Publications

1511 - 1520 of 9117 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2026
  • 2018
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2024.101669
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Understanding what aspects of Parkinson’s disease matter most to patients and families
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-024-71555-4
    Citation Count: 12
  • Summary Details
    OPEN
    Title: POLCAM: instant molecular orientation microscopy for the life sciences
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02382-8
    Citation Count: 20
  • Summary Details
    OPEN
    Title: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkae776
    Citation Count: 4
  • Summary Details
    OPEN
    Title: SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease
    Journal Name: Frontiers in Pharmacology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fphar.2024.1477009
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Mitophagy bridges glucose metabolism, inflammation and neuroprotection in astrocytes
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2026.2623987
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1100-1
    Citation Count: 197
  • Summary Details
    OPEN
    Title: Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0192497
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201708184
    Citation Count: 73
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.